State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
In a letter to the drug maker, the state treasurers warn that prices “disconnected from market forces will ultimately backfire." More
COVID-19 test charges range from one cent to $14,750, study finds
The CARES Act lets out-of-network providers set their own prices for COVID-19 diagnostic and antibody tests. A new study finds that has resulted in a wide range of charges. More
With No Legal Guardrails for Patients, Ambulances Drive Surprise Medical Billing
Studies show that at least half of ground ambulance rides across the nation leave patients with “surprise” medical bills. And a $300-a-mile ride is not unusual. More
The Impact of Coronavirus on Households Across America
This NPR, Harvard T.H. Chan School of Public Health, and RWJF polling series examines the most serious health and financial problems facing households across America prior to the expiration of federal coronavirus support programs. More
Coronavirus Tests Are Supposed to Be Free. The Surprise Bills Come Anyway.
Congress sought to ensure that patients would not face costs connected to the virus. But rules are not always being followed. More
Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers
Early in the pandemic, insurers expected the costs of treating COVID-19 would vastly increase medical spending. Instead, non-COVID care has plummeted and insurers have pocketed the result. More
‘How painful is the cost of your health care?’ The case for a new vital sign
"On a scale of 0 to 10, how painful is the cost of your health care?" All doctors should ask their patients about the financial pain of their health care. More
For COVID Tests, the Question of Who Pays Comes Down to Interpretation
Additional guidance issued late last month by the Trump administration added to the confusion. Some consumers may find themselves unexpectedly on the hook for the cost of a test. More
Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices. More
COVID Catch-22: They Got A Big ER Bill Because Hospitals Couldn’t Test For Virus
Americans who had coronavirus symptoms in March and April are getting big hospital bills — because they were not sick enough to get then-scarce COVID tests. More